Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| risk of fetal transmission in primary HSV outbreak |
|
Definition
|
|
Term
| risk of fetal transmission in recurrent HSV outbreak |
|
Definition
|
|
Term
| risk of HSV transmission to baby if had no outbreak (not delivery, 1T) |
|
Definition
|
|
Term
| prevalence of HSV1, 2, both |
|
Definition
| 1 - 60%, 2- 22%, both 13% |
|
|
Term
|
Definition
|
|
Term
| % of NEW cases of genital HSV that are HSV1 |
|
Definition
|
|
Term
|
Definition
|
|
Term
| how often do HSV 1 and 2 on average have outbreaks |
|
Definition
|
|
Term
| how long does it take for HSV Ab to be positive |
|
Definition
|
|
Term
| sens/spec of HSV diagnostic tests |
|
Definition
| culture 5-30% false negative, PCT #1 for CNS otherwise bad, cytology worst, Ab 90% sens 97% spec |
|
|
Term
| when to do HSV antibodies on someone - 6 |
|
Definition
| recurrence despite medication, atypical symptoms with negative culture, non-primary 1st episode, HSV in partner to rule out existing HSV, request of STI screen, MSM routine STI screen |
|
|
Term
| signs of a primary HSV episode (other than lesions)- 5 |
|
Definition
| 85% asymptomatic, 80% lymphadenopathy, 67% fever/myalgias, urinary retention, meningitis |
|
|
Term
| highest time of HSV shedding - 3 |
|
Definition
| during the 10-12d of a primary episode before crusting > during a recurrent episode for 4d before crusting > the entire 1st year after exposure |
|
|
Term
| when must medication be started during prodrome for it to be useful in HSV |
|
Definition
| prodrome is 12-24h, meds need to be within 24h of prodrome |
|
|
Term
| fetal syndrome with HSV in 1T - 3 |
|
Definition
| chorioretinitis, microcephaly, skin lesions |
|
|
Term
| who do you give HSV suppression to - 5 |
|
Definition
| 36wk gestation, recurrent, request, immune compromised, unaffected partner |
|
|
Term
| acyclovir dosing - initial, recurrent, prevention |
|
Definition
| initial - 400mg TID 7-10d, recurrent - 400mg TID 5d, prevention - 400mg BID |
|
|
Term
| valcyclovir dosing - initial, recurrent, prevention |
|
Definition
| initial - 1g BID 7-10d, recurrent 500mg BID 3d, prevention - 500mg QD to BID |
|
|
Term
| antivirals reduce HSV transmission __%, reduce shedding from __ to __% of days a month, and reduce recurrent episodes by __% |
|
Definition
| antivirals reduce HSV transmission 50%, reduce shedding from 11 to 3% of days a month, and reduce recurrent episodes by 80% |
|
|
Term
| without suppression affected babies by HSV after delivery have what prognosis |
|
Definition
| 50% die, 50% have permanent neurological sequalae |
|
|
Term
| HSV suppression after 36wk reduces CD by |
|
Definition
|
|
Term
| which genital lesions are associated with co-infection with HIV - 3 |
|
Definition
| canceroid, granuloma inguinalae, potentially syphillis im unclear |
|
|
Term
| which co-infections are associated with syphillis - 2 |
|
Definition
| potentially HIV im not sure, def canceroid |
|
|
Term
| cancheroid - bug, metabolism, and sign on staining |
|
Definition
| hemophilus ducrei, facultative aneroba, school of fish |
|
|
Term
| locations of cancheroid transmission - 3 |
|
Definition
|
|
Term
| cancheroid, lymphogranuloma venerium, granuloma inguinalae - lesion progression |
|
Definition
| C - papule > pustule > ulcer (halo, necrotic exudate) / LV - vesicle > papule > ulcer / GI - nodule > papule > ulcer (velvety, bleeds, beefy) |
|
|
Term
| cancheroid, lymphogranuloma venerium, granuloma inguinalae - pain |
|
Definition
| C - painful, LV/GI - painless |
|
|
Term
| cancheroid, lymphogranuloma venerium, granuloma inguinalae - lymphnode involvement |
|
Definition
| C - inguinal/suppurlative 50% / LV - inguinal/anogenital/groove 20% / GI - pseudobubo (subcutaneous granuloma) |
|
|
Term
| cancheroid, lymphogranuloma venerium, granuloma inguinalae - treatment |
|
Definition
| C - azithro 1g / LV - doxy 100mg BID 21d / GI - azithro 1g x3w |
|
|
Term
| cancheroid, lymphogranuloma venerium, granuloma inguinalae - how far back do you have to treat sexual contacts for |
|
Definition
| C - 7d / LV - 30d / GI - 60d |
|
|
Term
| lymphogranuloma venerium - bug |
|
Definition
| chlamydia trachomatis 11, 12, 13 |
|
|
Term
| lymphogranuloma venerium - where to get it 3 |
|
Definition
|
|
Term
| lymphogranuloma venerium - incidence |
|
Definition
|
|
Term
| lymphogranuloma venerium - additional sx to lesion and inguinal - 3 |
|
Definition
| cervicitis, urethritis, adenitis |
|
|
Term
| lymphogranuloma venerium - alternative treatments |
|
Definition
| erythromycin - important because cant use doxy in pregnancy |
|
|
Term
| granuloma inguinalae - incidence |
|
Definition
|
|
Term
| granuloma inguinalae - where to get it - 5 |
|
Definition
| carribean, India, Australia, S Africa, new guenie |
|
|
Term
| granuloma inguinalae - bug, gram stain signs |
|
Definition
| intracellylar gram negative klebsiella granulomatous, Donovan bodies on gimesa stain |
|
|
Term
| granuloma inguinalae - diagnosis |
|
Definition
| gimesa stain only, Donovan bodies |
|
|
Term
| lymphogranuloma venerium - diagnosis |
|
Definition
| NAAT is not FDA approved, + serology is helpful |
|
|
Term
| granuloma inguinalae - symptoms other than lesion and lymphadenopathy |
|
Definition
| extra genital infection can occur in mouth, bone, pelvis |
|
|
Term
| granuloma inguinalae - alternative treatments - 4 |
|
Definition
| doxycycline, cipro, erythro, bactrim |
|
|
Term
| granuloma inguinalae - what do you do if treatment isn't working |
|
Definition
| in 1-2d if not working do gentamicin IV 1mg/kg q8h |
|
|
Term
| highest age group with syphillis |
|
Definition
|
|
Term
| who should be screened for syphillis - 9 |
|
Definition
| MSM, HIV, on PREP, partner has it, incancerated, prostitute, males <29yo, locally high rates, pregnancy |
|
|
Term
| most definitive way to diagnose syphillis |
|
Definition
|
|
Term
| way to screen for and monitor syphillis |
|
Definition
|
|
Term
| ways to diagnose syphillis |
|
Definition
| treponemal - FTA-ABS / TP-PA, dark field microscopy |
|
|
Term
| when are syphillis screening tests positive |
|
Definition
|
|
Term
| when are syphillis screening tests false positive - 10 |
|
Definition
| rheumatic disease, infection, cancer, liver disease, IV drugs, pregnancy, SLE, HIV, malaria, small pox vaccine |
|
|
Term
| which tests for syphillis turn negative after treatment |
|
Definition
| the non-treponemal RPR/VDRL |
|
|
Term
| what is the transmission rate for 1 and multiple exposures to syphilis |
|
Definition
|
|
Term
| fetal complications of syphillis infection in utero - 4 |
|
Definition
| stillbirth, SAB, PTL, congenital infection |
|
|
Term
| how do you decrease the risk of stillbirth in syphilis |
|
Definition
| avoid delivery within 30d of treatment of primary and secondary syphilis |
|
|
Term
| fetal US signs of congenital syphilis - 4 |
|
Definition
| placentomeagly, IUGR, HSM, hydrops, poly |
|
|
Term
| signs of placetomeagly - 4 |
|
Definition
| large, thick, pale, few villi, necrotizing fasciitis |
|
|
Term
| early fetal signs of congenital syphillis - 9 |
|
Definition
| maculopapular rash, snuffles, jaundice, pneumonia, osteochondritis, iritis, HSM, thrombocytopenia, adenopathy |
|
|
Term
| late fetal signs of congenital syphillis - 11 |
|
Definition
| hutchinsons teeth, mulberry molars, interstitial keratitis, deafness, saddle nose, saber shins, MR, paresis, hydrocephalus, clutton joints, optic nerve atrophy |
|
|
Term
| incidence of jarsich-herxheimer reaction in syphillis treatment |
|
Definition
|
|
Term
| when does a jarsich-herxheimer reaction in syphillis treatment |
|
Definition
|
|
Term
| jarsich-herxheimer reaction in syphillis treatment |
|
Definition
|
|
Term
| timing of the stages of syphillis |
|
Definition
primary - 3-6wk
secondary - 6wk-6mo
early latent - <1y
late latent - >1y
tertiary - n/a
neuro - n/a |
|
|
Term
| which stages of syphillis are infectious |
|
Definition
| primary, secondary, potentially early latent |
|
|
Term
| fetal transmission rates in each stage of syphillis |
|
Definition
primary - 40-80%
secondary - 40-80%
early latent - 40-50%
late latent - <10%
tertiary - <10%
CNS - depends on stage corresponding |
|
|
Term
| signs of primary syphillis - 2 |
|
Definition
| painless cancher, painless lymphadenopathy |
|
|
Term
| signs of secondary syphillis - 8 |
|
Definition
| maculopapular rash 90% (rough, red-brown, palms, soles), condyloma lata 15% (painless mucosal), lymphadenopathy 70%, fever, sore throat, headache, weight loss, hair loss |
|
|
Term
| signs of tertiary syphillis - 6 |
|
Definition
| gumma 50% (soft tissue growth), cardiac 25% (endocarditis, aneurysm, aortic insufficiency), tabeius dorsalis 25%, argyle Robertson pupil 25% |
|
|
Term
| signs of argyle Robertson pupil |
|
Definition
| can accommodate but can not react |
|
|
Term
| 3 types of neurosyphillis |
|
Definition
| meningeal (acute, chronic), porchematous, granulomatous |
|
|
Term
| signs of porchematous neurosyphilis - 6 |
|
Definition
| pain, parasthesias, decreased DTRs, ataxia, tabeis dorsalis, argyle Robertson pupil |
|
|
Term
| treatment of primary and secondary syphilis and early latent |
|
Definition
| benzathine pcn g 2.4 mil U IM x1 |
|
|
Term
| treatment of late latent and tertiary syphillis |
|
Definition
| benzathine pcn g 2.4 mil U IM x3 over 3 weeks |
|
|
Term
| treatment of neurosyphillis |
|
Definition
| aqueous crystalline PCN G 18-24 million units (3-4 mil U q4h IV x10-14d) |
|
|
Term
| when in syphillis should you do a LP - 3 |
|
Definition
| opthamologic symptoms, CNS symptoms, tertiary syphillis |
|
|
Term
| how far back do you need to test partners for syphillis |
|
Definition
| primary - 3mo, secondary - 6mo, early latent - 12mo |
|
|
Term
| how do titers guide syphilis treatment |
|
Definition
| primary and secondary - should drop 4x in 6mo and 8x in 12mo / early latent should drop 4x in 12mo ----- if not then get HIV testing, retreat, and do LP |
|
|
Term
|
Definition
|
|
Term
| most commonage group chlamydia |
|
Definition
|
|
Term
| chance of getting chlamydia in 1 encounter |
|
Definition
|
|
Term
| fetal chlamydia signs - 2 |
|
Definition
| conjunctivitis, pneumonia |
|
|
Term
|
Definition
| sexually active <25yo, pregnancy at NOB and 3T if <25yo |
|
|
Term
| best diagnosis for chlamydia |
|
Definition
| NAAT >95% s/s, self swab = cervical swab, urine is 10% less s/s |
|
|
Term
|
Definition
|
|
Term
| alternative treatments chlamydia - 4 |
|
Definition
| doxy, erythrom, levofloxacin, ofloaxcin |
|
|
Term
| how far back should you give expedited treatment to partners in chlamydia |
|
Definition
|
|
Term
| how long should someone with chlamydia abstain after treatment |
|
Definition
|
|
Term
| indications for TOC chlamydia - 3 and timing |
|
Definition
| pregnancy, concern for compliance, persistent symptoms, earliest 3wk but usually 3mo, do test of re-infection in 3mo on everyone |
|
|
Term
| likelihood of re-infection of chlamydia in next 12mo |
|
Definition
|
|
Term
| #2 most common STI in the world |
|
Definition
|
|
Term
| percent co-infection gonorrhea and chlamydia |
|
Definition
|
|
Term
| percent of PID with positive gonorrhea |
|
Definition
|
|
Term
| who transfers gonorrhea to who |
|
Definition
| female to male 25%, male to female 50-90% |
|
|
Term
|
Definition
| NAAT 95% S/S same for urine, self, cervix, culture 65-85% sens 100% specific, DNA probe 99% s/s, gram stain 65% |
|
|
Term
| which STI is most likely to affect the bartholins/skenes |
|
Definition
|
|
Term
| percent of gonorrhea asymptomatic |
|
Definition
|
|
Term
| percent of chlamydia asymptomatic |
|
Definition
|
|
Term
| percent of gonorrhea that progresses to PID untreated |
|
Definition
|
|
Term
|
Definition
| ceftriaxone 250mg IM + azithromycin 1g PO |
|
|
Term
| alternative treatment gonorrhea |
|
Definition
| cefixipime and azithromycin |
|
|
Term
| how far back should you do expedited partner treatment for gonorrhea |
|
Definition
|
|
Term
| when do you retest for gonorrhea |
|
Definition
| no TOC unless sx, do test for re-infection in 3mo |
|
|
Term
| signs of disseminated gonorrhea - 6 |
|
Definition
| skin lesions, peripherial asymmetric arthralgia, septic arthritis, perihepatitis, endocarditis, meningitis |
|
|
Term
| treatment of disseminated gonorrhea |
|
Definition
| cefoxitin 1g IV q24h (q12h if meningitis or endocarditis) |
|
|
Term
| #1 non-viral or bacterial STI in the US |
|
Definition
|
|
Term
| what percent of all vaginitis is trich |
|
Definition
|
|
Term
|
Definition
| NAAT 95-100% s/s, culture 95% s/s, wet prep 50-70%, pap 99%s 60% spec |
|
|
Term
| percent of trich that is asymptomatic |
|
Definition
|
|
Term
|
Definition
|
|
Term
| treatment of resistant trich |
|
Definition
| continue metronidazole for 7d or can do tinidazole instead, do susceptibility testing |
|
|
Term
|
Definition
| 3mo may perform NAAT as early as 3wk |
|
|
Term
|
Definition
|
|
Term
| treatment of pubic lice and scabies |
|
Definition
| premetherin 1% for 10 min, malathion, ivermectin, lindane (not safe in pregnancy) |
|
|
Term
| how long does the scabies rash last |
|
Definition
|
|
Term
| what is the name for scabies bug |
|
Definition
|
|
Term
|
Definition
| self reported in 4.4% of sexually active women |
|
|
Term
| what percent of PID were positive for gonorrhea and or chlamydia |
|
Definition
|
|
Term
|
Definition
| mycoplasma, ureaplasma, gardinerella, H. flu, bacteroides, E. coli |
|
|
Term
| most common age group for PID |
|
Definition
|
|
Term
| definitive diagnosis of PID - 3 |
|
Definition
| endometritis on EMBx, TVUS/MRI with hydro or TOA, LSC with fitz hugh Curtis 10% or adhesions |
|
|
Term
| CDC diagnostic criteria for PID |
|
Definition
| uterine/adenexa/CMT tenderness + pelvic pain + sexually active = PID unless proven otherwise |
|
|
Term
| supportive CDC criteria for PID diagnosis - 6 |
|
Definition
| >101F, discharge, WBC in vaginal fluid, elevated ESR or CRP, G/C infection |
|
|
Term
| rate of infertility in PID after 1, 2, 3+ episodes |
|
Definition
| 1 - 10%, 2 - 20%, 3 - 40% |
|
|
Term
|
Definition
| ceftriaxone 250mg IM + doxy 100mg BID +/- metronidazole 500mg x14d |
|
|
Term
| alternative outpatient treatment for PID |
|
Definition
| cefoxitin + probenecid + doxy +/- metronidazole |
|
|
Term
| treatment for PID outpatient in PCN allergy |
|
Definition
| must test for gonorrhea resistance/susceptibility, levofloxacin + metronidazole |
|
|
Term
| when do you have the patient come back after dx and outpatient tx of PID |
|
Definition
|
|
Term
| inpatient treatment for PID |
|
Definition
| cefotetan 2g IV q12h + doxy 2g IV q6h |
|
|
Term
| alternative inpatient treatment for PID |
|
Definition
| cefoxitin 2g IV q6h + doxy 100mg PO/IV q12h |
|
|
Term
| PID inpatient treatment in PCN allergy |
|
Definition
| clinda + gent, amp or sulbactam + doxy |
|
|
Term
| what to do with IUD in PID |
|
Definition
| leave it unless not improving |
|
|
Term
| hospitalization criteria PID - 7 |
|
Definition
| surgical emergency cannot be excluded, TOA, pregnancy, PO intolerance, high fever, not responding to outpatient therapy, HIV with low CD4 |
|
|
Term
| what increases the risk of tubal infertility in PIT |
|
Definition
|
|
Term
| when do you send a TOA for ID draining |
|
Definition
| symptoms don't improve in 3-4d of IV antibiotics |
|
|
Term
| when do you do a surgery for a TOA - 5 |
|
Definition
| sepsis, >10cm, unstable, ruptured, PMP |
|
|
Term
| _% of TOA that will respond to abx at <__cm, __% of TOA that will respond to abx at >__cm |
|
Definition
| 85% will respond <4cm, 40% will respond >10cm |
|
|
Term
| #1 risk factor for endometritis |
|
Definition
|
|
Term
| treatment of acute endometritis |
|
Definition
| ceftriaxone 250mg IM + doxy 100mg BID x14d +/- metronidazole 500mg BID x14d |
|
|
Term
| treatment of chronic endometritis |
|
Definition
|
|
Term
|
Definition
| 25% of patients, 50% of vaginal discharge |
|
|
Term
|
Definition
| gardnerella, peptostreptococcus, prevotella, mobiluncus, bacteroides, fusobacterium, atopobium vaginae, mycoplasma hominis |
|
|
Term
| who should get screened for BV if asymptomatic |
|
Definition
| history of PTD at 24-28wk |
|
|
Term
|
Definition
| BV >4.5, trich >4.5, yeast <4.5 |
|
|
Term
|
Definition
| >3 documented episodes in 12mo |
|
|
Term
|
Definition
| gram staining of vaginal discharge for BV, gold standard |
|
|
Term
|
Definition
| vaginal discharge, pH >4.5, fishy odor, >20% clue cells |
|
|
Term
|
Definition
| metronidazole 250mg TID x7d |
|
|
Term
| alternative treatments for BV - 2 |
|
Definition
| clinidamycin 300mg BID x7d, scenidazole sing 2g oral ganules |
|
|
Term
|
Definition
| yeast infection, nausea, headache |
|
|
Term
| % of BV treatmet that will result in vaginal candidia |
|
Definition
|
|
Term
| complications of BV in pregnancy - 3 |
|
Definition
|
|
Term
| complicated vaginal yeast criteria - |
|
Definition
| recurrent (4+/y), severe symptoms, suspected not albicans, diabetes, immune suppression, pregnancy |
|
|
Term
| indications for a fungal culture - 3 |
|
Definition
| recurrent infection, possible no albicans, si/sx without a positive microscopy |
|
|
Term
| s/s of microscopy for yeast |
|
Definition
|
|
Term
| transmission of HIV no meds - CD/SVD |
|
Definition
| SVD 20%, emergent CD 19%, planned CD 7% |
|
|
Term
| transmission of HIV on meds - CD/SVD |
|
Definition
| SVD 4%, emergent CD 10%, planned CD 2% |
|
|
Term
| HIV transmission percutaneous |
|
Definition
|
|
Term
| HIV transmission mucomembraneous |
|
Definition
|
|
Term
| all comers HIV sreening guidelines |
|
Definition
|
|
Term
| candidates for annual HIV screening - 5 |
|
Definition
| IV drug users, prostitutes, partner with HIV, MSM, >1 partner since last test |
|
|
Term
| screening for HIV in pregnancy |
|
Definition
| at NOB, in 3T if high risk |
|
|
Term
| candidates for 3T HIV testing - 6 |
|
Definition
| population risk >1:1000, symptoms, STI in past 12mo, IV drug user, new partner, >1 partner |
|
|
Term
| when is the window period for HIV |
|
Definition
| before 4-8wk post infection |
|
|
Term
| timeline of HIV infection |
|
Definition
| initial 3-6wk, acute HIV syndrome 1w-3m, HIV immune response 1-2wk, HIV latency 10y, AIDS 2y, death |
|
|
Term
| percent of HIV that get acute HIV syndrome |
|
Definition
|
|
Term
| signs of acute HIV syndrome clinical - 7 |
|
Definition
| fever, sunburn rash, myalgia, HA, sore throat, diarrhea, adenopathy |
|
|
Term
| lab changes in acute HIV syndrome |
|
Definition
| initial increase then decrease in T4 |
|
|
Term
| infections associated with CD4 <400 - 5 |
|
Definition
| candidia, oral hairy leukoplakia, shingles, HSV, listeria |
|
|
Term
| infections associated with CD4 <200 - 7 |
|
Definition
| PCP, kaposki sarcoma, coccidiomyosis, cryptosporidiosis, CMV, brain toxo, HIV encephalopathy |
|
|
Term
| infections associated with CD4 <50 - 6 |
|
Definition
| MAC, histoplasmosis, CMV retinitis, leukoencephalopathy, HIV dementia |
|
|
Term
| labs to get at NOB in HIV - 13 |
|
Definition
| CD4, HIV RNA, CBC, LFTs, Cr, hep B, CMV, toxo, PPD, VDRL, G/C, pap, partner STI testing |
|
|
Term
| how often to get CD4/HIV RNA in pregnancy |
|
Definition
| q3-6mo, always 1mo after treatment change/start |
|
|
Term
| vaccines to make sure has in HIV/pregnancy - 4 |
|
Definition
| pneumo, flu, hepatitis B, H. flu B |
|
|
Term
|
Definition
| neucloside reverse transcriptase inhibitor - zidovudine, non-neucloside reverse transcriptase inhibitor - nevirapine, protease inhibitor - ritonavir |
|
|
Term
|
Definition
| tenofovir and embricitabine |
|
|
Term
| how many days can you give of prep at a time |
|
Definition
|
|
Term
|
Definition
| HIV Ab, STI screen, hep B screen |
|
|
Term
|
Definition
| know HIV partner or sex in high HIV social network PLUS ONE - inconsistent condoms, STI positive, prostitution, IV drugs, alcohol dependence, incarceration, unknown HIV partner status |
|
|
Term
| monitoring involved in prep - 3 |
|
Definition
| HIV q3mo, assess risk q2-3mo, STI questions and testing as indicated |
|
|
Term
| what can make prep work better and how much - 2 |
|
Definition
| condoms 80% reduction combined, low viral load 96% reduction combined |
|
|
Term
| what can make prep work worse |
|
Definition
| spermicide with nonoxynol-9 increases HIV transmission |
|
|
Term
|
Definition
| patient request, positive HIV |
|
|
Term
| how long do you need to be on prep before anal and vaginal intercourse or sharing IV drugs |
|
Definition
| receptive anal 7d, insertive anal 20d, vaginal 20d, IV drugs 20d |
|
|
Term
| what is the average and possible prep efficacy |
|
Definition
| average 62%, possible 92-99% |
|
|
Term
| with is the efficacy of pep |
|
Definition
|
|
Term
| what are the components of pep |
|
Definition
| trnofovir, embticidibine, raltigravir |
|
|
Term
|
Definition
|
|
Term
| how long should someone on pep abstain |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| nausea, vomiting, diarrhea, headache, hepatitis, hyperglycemia, pancytopenia |
|
|
Term
| what is the high risk pep |
|
Definition
| zidovudine, lamivudine, lopinovir-ritonivir |
|
|
Term
|
Definition
| large bore IV or large blood volume exposure |
|
|
Term
|
Definition
| partner with HIV, sex with high prevalence population, inconsistent condom use, STI, MSM, sex workers, IV drugs, etoh dependence, incarcerated, anal sex without condoms |
|
|
Term
| when is pep given after an assault |
|
Definition
<72h - if know HIV assailent, consider if HIV unknown
>72h - not recommended |
|
|
Term
| pregnancy management - HIV pos, no meds, no labs |
|
Definition
| CD 38wk, 3 part SVD, baby ZVD - consider SVD only if ruptured and laboring |
|
|
Term
| pregnancy management - HIV pos, on meds, RNA >1000 |
|
Definition
| CD 38wk, IV zvd 3h pre-op, zvd for baby |
|
|
Term
| pregnancy management - HIV pos, on meds, RNA <1000 |
|
Definition
| SVD 39wk, ZVD for mom and baby, no FSE |
|
|
Term
| % with HIV that don't know it |
|
Definition
|
|
Term
|
Definition
|
|
Term
| % HIV diagnosed in pregnancy |
|
Definition
|
|
Term
| % HIV from heterosexual contact |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| teratogen stavuidine with didanosine |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| condoms reduce HIV transmission % |
|
Definition
|
|
Term
| transmission of HIV with breastfeeding |
|
Definition
|
|
Term
| % cancer patients with HIV |
|
Definition
|
|
Term
| considerations for those on antiretrovirals and HRT |
|
Definition
| may need higher HRT levels, fosamprenavir levels can be lowered when on HRT |
|
|
